INVESTOR ACTION ALERT: The Schall Law Firm Announces the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
17
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tyme Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Feb. 06, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tyme Technologies, Inc. (“Tyme” or “the Company”) (NASDAQ: TYME ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between June 22, 2018 and November 19, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before March 25, 2019.         

If you are a shareholder who suffered a loss, click here to participate .

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at  www.schallfirm.com , or by email at  brian@schallfirm.com .

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Tyme failed to design its Phase II Study of its drug candidate SM-88 in a way that could present reliable results on its efficacy for pancreatic cancer. Specifically, the Company failed to include a control group, instead relying on historical control data. Not including a control group in the Phase II trial rendered the study’s results unreliable. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Tyme, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm Brian Schall, Esq., Sherin Mahdavian, Esq., www.schallfirm.com Office: 310-301-3335 Cell: 424-303-1964 info@schallfirm.com

SOURCE:

  The Schall Law Firm

Scroll down for more posts ▼

Top 10 Most Recent News Articles

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 543

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 117

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 44

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 8

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 231

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 0

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 71

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 349

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Game-Changing Trends Transforming Food Choices

Updated Category News Views 367

Nourish Food Marketing Unveils Influential Trends for 2025 Nourish Food Marketing, a dynamic agency specializing in the food, beverage, and agriculture sector, recently unveiled its 9th annual Trend Report for 2025. This insightful report dives deep into nine major trends that will not only shape the industry but will also significantly influence consumer behavior in the...

Continue Reading
Investigation into Sezzle Inc. Over Securities Concerns

Updated Category News Views 278

Introduction to Sezzle Inc. Investigation Sezzle Inc. is currently under investigation by the Portnoy Law Firm, a notable name in securities litigation. This inquiry centers around potential securities fraud that may impact investors significantly. For those with concerns about their investments in Sezzle, it's important to understand the details surrounding this...

Continue Reading
Conagra Brands Sees Analyst Revisions Post Mixed Performance

Updated Category News Views 119

Conagra Brands Experiences Uneven Results in Latest Quarter Conagra Brands Inc (NYSE: CAG) has faced a challenging environment, reflecting a mixed performance in its latest quarterly results. The company reported earnings of 45 cents per share for the quarter, slightly surpassing expectations that predicted 44 cents per share. However, the revenue aspect did not align as...

Continue Reading
CNOOC Limited Achieves Record Oil and Gas Production Growth

Updated Category News Views 204

CNOOC Limited Achieves New Milestones in Oil and Gas Production CNOOC Limited has unveiled impressive operational results, marking a significant increase in oil and gas production. The company's dedication to strategic growth has propelled it to a record-breaking first half of 2025. As production metrics shine, CNOOC Limited (SEHK: 00883 (HKD Counter) and 80883 (RMB...

Continue Reading
Growth Prospects of the Automotive Bearing Market Ahead

Updated Category News Views 166

Understanding the Automotive Bearing Market Growth The global Automotive Bearing Market is experiencing remarkable growth, spurred by the rapid adoption of electric vehicles (EVs), advances in lightweight materials, and an increasing emphasis on fuel efficiency. Despite facing challenges like fluctuating raw material prices, supply chain issues, and counterfeit products,...

Continue Reading